AMA
Wei T, Duan Z, Chen H, Xiang Z, Li C. Assessment of adalimumab used in a patient
with hemorrhagic rheumatoid neutrophilic dermatosis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2026;43(2):203-205. doi:10.5114/ada.2026.161103.
APA
Wei, T., Duan, Z., Chen, H., Xiang, Z., & Li, C. (2026). Assessment of adalimumab used in a patient
with hemorrhagic rheumatoid neutrophilic dermatosis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 43(2), 203-205. https://doi.org/10.5114/ada.2026.161103
Chicago
Wei, Tianqi, Zhimin Duan, Hao Chen, Zhi Xiang, and Cheng-Rang Li. 2026. "Assessment of adalimumab used in a patient
with hemorrhagic rheumatoid neutrophilic dermatosis". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 43 (2): 203-205. doi:10.5114/ada.2026.161103.
Harvard
Wei, T., Duan, Z., Chen, H., Xiang, Z., and Li, C. (2026). Assessment of adalimumab used in a patient
with hemorrhagic rheumatoid neutrophilic dermatosis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 43(2), pp.203-205. https://doi.org/10.5114/ada.2026.161103
MLA
Wei, Tianqi et al. "Assessment of adalimumab used in a patient
with hemorrhagic rheumatoid neutrophilic dermatosis." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 43, no. 2, 2026, pp. 203-205. doi:10.5114/ada.2026.161103.
Vancouver
Wei T, Duan Z, Chen H, Xiang Z, Li C. Assessment of adalimumab used in a patient
with hemorrhagic rheumatoid neutrophilic dermatosis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2026;43(2):203-205. doi:10.5114/ada.2026.161103.
